PhD Pharmacology. 30 years in drug development. Market authorization of 7 drugs in EU/US.
Katja Görnemann is a certified EFFAS financial analyst specialized in Equity and Fixed Income Investor Relations (IR), Corporate Development, Corporate Finance and Corporate Communication. His professional development has focused on the preparation and execution of IPOs (Gestevisión Telecinco, Talgo), corporate bond issuances, as well as the design and implementation of IR strategic plans in multinational…
PhD Molecular Biology. +20 years in Licensing, Business Analytics and Strategic Consulting at Roche, PharmaMar and ActeaVentures.
PhD in Biotechnology. In vivo / in vitro, diagnostic techniques, clinical data models and data quality specialist.
Degree in Economics. Experienced in financials. Former Associate Professor.
MD. Physician. Master in Medical Management and Clinical Management.
Engineer, serial entrepreneur, angel investor and director of a business accelerator. Senator at World Business Angels Forum.
Degree in Economics and Business and MBA. Experienced in managing several SMEs.
MD/PhD Physician and Pathologist. +15 years in cancer research.